NUTRA PHARMA CORP. Operating Lease Right-of-Use Assets
NUTRA PHARMA CORP. (NPHC) had Operating Lease Right-of-Use Assets of $23.40 thousand as of 2025-09-30, per its 10-Q filed 2026-04-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-05-20
- 2025-09-30: Operating Lease, Right-of-Use Asset $23.40K.
- 2025-06-30: Operating Lease, Right-of-Use Asset $46.32K.
- 2025-03-31: Operating Lease, Right-of-Use Asset $68.78K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $90.78K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2025-09-30 | $23.40K 10-Q · filed 2026-04-06 |
| 2025-06-30 | $46.32K 10-Q · filed 2026-03-25 |
| 2025-03-31 | $68.78K 10-Q · filed 2026-03-11 |
| 2024-12-31 | $90.78K 10-K · filed 2026-05-20 |
| 2024-09-30 | $112.35K 10-Q · filed 2026-01-02 |
| 2024-06-30 | $133.49K 10-Q · filed 2025-12-23 |
| 2024-03-31 | $154.21K 10-Q · filed 2025-12-17 |
| 2023-12-31 | $174.52K 10-K · filed 2026-02-17 |
| 2023-09-30 | $194.44K 10-Q · filed 2025-10-28 |
| 2023-06-30 | $213.98K 10-Q · filed 2025-10-23 |
| 2023-03-31 | $233.15K 10-Q · filed 2025-10-16 |
| 2022-12-31 | $251.95K 10-K · filed 2025-11-24 |
| 2022-09-30 | $43.40K 10-Q · filed 2022-11-21 |
| 2022-06-30 | $58.94K 10-Q · filed 2022-08-22 |
| 2022-03-31 | $74.99K 10-Q · filed 2022-05-20 |
| 2021-12-31 | $93.81K 10-K · filed 2025-09-03 |
| 2021-09-30 | $112.12K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $136.65K 10-Q · filed 2021-09-24 |
| 2021-03-31 | $147.67K 10-Q · filed 2021-09-17 |
| 2020-12-31 | $144.01K 10-K · filed 2022-04-15 |
| 2020-09-30 | $145.62K 10-Q · filed 2021-08-12 |
| 2020-06-30 | $168.23K 10-Q · filed 2021-08-05 |
| 2020-03-31 | $200.28K 10-Q · filed 2021-07-23 |
| 2019-12-31 | $207.53K 10-K · filed 2021-09-08 |
| 2019-09-30 | $220.53K 10-Q · filed 2021-05-14 |
| 2019-06-30 | $251.89K 10-Q · filed 2021-05-07 |
| 2019-03-31 | $265.93K 10-Q · filed 2021-04-05 |
| 2019-01-02 | $281.18K 10-K · filed 2021-07-01 |